Safeguard Scientifics (SFE) 18.54 $SFE
Webster Bank and Standard Register Sign Multi-Year Customer Communications Services Agreement
Business Wire - Wed Feb 11, 8:00AM CST
Standard Register (NYSE: SR), a leading provider of workflow, content and analytics, announced today the signing of a multi-million dollar agreement with Webster Bank. Under the agreement, Standard Register renewed its contract through 2018 to provide enterprise print management and promotional marketing programs and expanded the relationship to include electronic bill presentment and payment (EBPP) services.
SFE: 18.54 (+0.06), SR: 1.25 (+0.08)
Aventura Raises $14 Million Series C Financing Co-Led by Safeguard Scientifics and Merck GHIF
GlobeNewswire - Mon Feb 09, 7:06AM CST
via PRWEB - Aventura, a leader in healthcare workflow optimization software solutions, today announced that it raised a $14 million Series C financing round, which was oversubscribed, co-led by Safeguard Scientifics (NYSE:SFE) and Merck Global Health Innovation Fund (Merck GHI). Existing investors Excel Venture Management, HLM Venture Partners, and Memorial Care Innovation Fund also participated in the round. Aventura will use proceeds from the funding to expand sales and marketing, business development, and customer support, as well as accelerate product development.
SFE: 18.54 (+0.06), MRK: 58.81 (-0.07)
Safeguard Scientifics to Release Fourth Quarter and Full-Year 2014 Financial Results on Thursday, March 5th
GlobeNewswire - Thu Feb 05, 10:00AM CST
via PRWEB - Safeguard Scientifics, Inc. (NYSE:SFE) will release its financial results for the fourth quarter and year-ended December 31, 2014 prior to market open on Thursday, March 5, 2015.
SFE: 18.54 (+0.06)
Velano Vascular Raises $5 Million Series A Financing Led by First Round Capital, Two Hospitals and Notable Healthcare Industry Veterans
Business Wire - Thu Feb 05, 6:31AM CST
Velano Vascular, a medical technology company with the goal of reducing needle sticks during the inpatient blood draw procedure, today announced that the company has closed a $5 million Series A financing. Investors include First Round Capital, White Owl Capital, Kapor Capital, and Safeguard Scientifics (NYSE: SFE), in addition to health-industry angels and two thought-leading hospitals. Velano Vascular plans to use proceeds from this financing to move into clinical evaluation and early commercialization with select hospital partners.
SFE: 18.54 (+0.06)
Trice Medical Extends Series B Financing to $18.1 Million
GlobeNewswire - Wed Feb 04, 7:06AM CST
via PRWEB - Trice Medical(TM), a private diagnostics company focused on micro invasive technologies, today announced that it closed its Series B financing totaling $18.1 million. The company raised an additional $6.5 million to supplement the initial $11.6 million, which was announced in July 2014. HealthQuest Capital led the extension. Safeguard Scientifics, Inc. (NYSE:SFE) provided an additional $1.15 million in the extension to bring its total capital deployed to $6.15 million. BioStar Ventures and other existing investors completed the round. Proceeds will be used to support Trice Medical's commercialization and marketing of its initial diagnostic arthroscopy product, mi-eye(TM), into the physician's office.
SFE: 18.54 (+0.06)
U.S. Congressman Patrick Meehan to Present Keynote Address at 22nd Annual Groundhog Investment Forum
Business Wire - Tue Feb 03, 9:15AM CST
Emerald Asset Management, Inc. has announced that U.S. Congressman Patrick Meehan will present the keynote address to the close the 22nd annual Groundhog Day Investment Forum on Thursday, February 5th in Philadelphia. Currently serving his third term in Congress, Congressman Meehan represents Pennsylvania's 7th Congressional District, serving on the influential House Ways and Means Committee, as well as the Committee on Ethics. In the 113th Congress, Meehan chaired the House Homeland Security Committee's Subcommittee on Cybersecurity. Meehan focused on protecting America's critical infrastructure -- our transportation, energy, financial and communications systems -- from cyberattack. "Cybersecurity is a critical issue for our nation and for every American company," said Emerald CEO Joseph E. Besecker. "We welcome Congressman Meehan and his are eager to hear about Washington's ongoing efforts to protect the Homeland, including our vital technology-related assets," he said. Among the investment themes for 2015 identified by Emerald is the growing attention to cybersecurity and companies that provide related services and solutions.
SFE: 18.54 (+0.06), CODI: 16.61 (+0.03), MATW: 49.13 (+0.73), CUBI: 22.29 (-0.14), SASR: 25.85 (-0.18), TREX: 44.63 (-0.01), SN: 15.21 (-0.12), RBPAA: 1.83 (+0.02), STON: 28.02 (-0.32), INO: 6.80 (-0.15), WTR: 25.85 (-0.45), ALNY: 95.54 (+1.67), STBA: 28.60 (+0.03), MRNS: 10.94 (-0.06), APOG: 45.54 (+0.27), KWR: 86.40 (+1.20), BMTC: 29.89 (-0.01), EPAM: 54.08 (-1.93), ACTA: 16.07 (+0.08), GSVC: 10.22 (+0.12)
Investment Industry to Gather in Philadelphia at 22nd Annual Groundhog Day Investment Forum
Business Wire - Thu Jan 29, 11:05AM CST
Emerald Asset Management, Inc. will welcome hundreds of investment industry professionals to the 22nd annual Emerald Groundhog Day Investment Forum, scheduled to be held on Thursday, February 5th at the Radisson Blu Warwick Hotel in Philadelphia, PA. "Each year we say that the investment year begins in earnest with our annual Forum," said Emerald CEO and Founder Joseph E. Besecker. "This year with increased market volatility and an uncertain economic outlook, hearing directly from corporate leaders and our team of analysts and portfolio managers is even more imperative," he said. Public company senior managers, investment portfolio managers and research analysts come together to review 2014 and provide their initial outlook to 2015 and beyond. This year's Forum will include sessions focusing on cyber security, advances in biotechnology, community and regional banks, income-oriented and alternative investments and ongoing innovations by corporate America generating potential investment opportunities.
SFE: 18.54 (+0.06), MATW: 49.13 (+0.73), CUBI: 22.29 (-0.14), SASR: 25.85 (-0.18), TREX: 44.63 (-0.01), SN: 15.21 (-0.12), RBPAA: 1.83 (+0.02), STON: 28.02 (-0.32), INO: 6.80 (-0.15), WTR: 25.85 (-0.45), ALNY: 95.54 (+1.67), STBA: 28.60 (+0.03), MRNS: 10.94 (-0.06), APOG: 45.54 (+0.27), KWR: 86.40 (+1.20), BMTC: 29.89 (-0.01), EPAM: 54.08 (-1.93), ACTA: 16.07 (+0.08), GSVC: 10.22 (+0.12)
Raymond Hill, Former IMS and InVentiv Health Executive, Joins Medivo's Board of Directors
GlobeNewswire - Mon Nov 17, 7:19AM CST
via PRWEB - Medivo, Inc., a leader in lab data analytics, today announced that Raymond Hill has been elected to Medivo's board of directors. As President of InVentiv Health Clinical, Mr. Hill was instrumental in driving EBITDA growth, reducing attrition, securing key strategic partnerships, and re-positioning the company. As President of IMS Consulting and Services, Mr. Hill spearheaded work in portfolio strategy, pricing and market access, launch excellence, managed markets, sales force effectiveness, and commercial outsourcing. Mr. Hill also served as the CEO of Pharmaceutical Product Development Inc.
SFE: 18.54 (+0.06)
Safeguard Scientifics Appoints Mara G. Aspinall to its Board of Directors
PRWeb - Mon Oct 27, 8:07AM CDT
Safeguard Scientifics, Inc. (NYSE:SFE) today announced that it appointed Mara G. Aspinall to its board of directors. Ms. Aspinall has a track record of success as an entrepreneur and healthcare industry visionary that will drive value for Safeguard's shareholders. Inclusive of Aspinall's appointment, Safeguard currently has nine board members.
SFE: 18.54 (+0.06)
Safeguard Scientifics' (SFE) CEO Stephen Zarrilli on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Fri Oct 24, 10:51AM CDT
SFE: 18.54 (+0.06)
Safeguard Scientifics Announces Third Quarter 2014 Financial Results
GlobeNewswire - Fri Oct 24, 5:19AM CDT
via PRWEB - Safeguard Scientifics, Inc. (NYSE:SFE) today announced third quarter 2014 financial results. For the three months ended September 30, 2014, Safeguard's net loss was $14.0 million, or $0.68 per share, compared to a net loss of $19.4 million, or $0.90 per share, for the same period in 2013. For the nine months ended September 30, 2014, Safeguard's net income was $10.0 million, or $0.47 per share, compared to a net loss of $59.5 million, or $2.80 per share, for the same period of 2013.
SFE: 18.54 (+0.06)
Safeguard Scientifics misses by $0.13
Seeking Alpha - at Seeking Alpha - Fri Oct 24, 5:17AM CDT
SFE: 18.54 (+0.06)
Notable earnings before Friday’s open
Seeking Alpha - at Seeking Alpha - Thu Oct 23, 4:30PM CDT
WYN: 90.57 (+0.93), SFE: 18.54 (+0.06), F: 16.30 (-0.06), OCR: 76.89 (+0.14), B: 37.40 (+0.44), SXC: 17.32 (+0.58), VTR: 76.61 (-0.41), UPS: 101.79 (+0.38), DLPH: 78.70 (+0.64), CHH: 61.75 (+1.14), LYB: 89.99 (+0.19), COG: 28.10 (+0.18), SHPG: 239.82 (+6.11), TCB: 15.86 (+0.03), AVY: 53.79 (+0.14), AAN: 31.35 (-0.09), MGLN: 60.98 (+0.10), STT: 76.93 (-0.46), FNFG: 8.84 (+0.04), IMGN: 7.19 (unch), EDU: 18.79 (+0.01), BMY: 60.04 (+0.56), DTE: 81.56 (-2.43), LEA: 108.70 (-0.73), MCO: 98.22 (+0.01), FLIR: 33.01 (-0.23), IMS: 25.68 (+0.22), LPNT: 69.04 (-0.06), ERIC: 12.77 (-0.02), PG: 85.90 (-0.13), IDXX: 159.08 (+1.72), WBC: 109.54 (+6.48), NDAQ: 49.48 (-0.27), CL: 70.08 (+0.23)
Safeguard Scientifics' CEO Hosts 2014 Investor Day Conference (Transcript)
SA Transcripts - at Seeking Alpha - Wed Oct 15, 9:04PM CDT
SFE: 18.54 (+0.06)
Webster Bank and Standard Register Sign Multi-Year Customer Communications Services Agreement
Business Wire - Wed Feb 11, 8:00AM CST
Standard Register (NYSE: SR), a leading provider of workflow, content and analytics, announced today the signing of a multi-million dollar agreement with Webster Bank. Under the agreement, Standard Register renewed its contract through 2018 to provide enterprise print management and promotional marketing programs and expanded the relationship to include electronic bill presentment and payment (EBPP) services.
SFE: 18.54 (+0.06), SR: 1.25 (+0.08)
Aventura Raises $14 Million Series C Financing Co-Led by Safeguard Scientifics and Merck GHIF
GlobeNewswire - Mon Feb 09, 7:06AM CST
via PRWEB - Aventura, a leader in healthcare workflow optimization software solutions, today announced that it raised a $14 million Series C financing round, which was oversubscribed, co-led by Safeguard Scientifics (NYSE:SFE) and Merck Global Health Innovation Fund (Merck GHI). Existing investors Excel Venture Management, HLM Venture Partners, and Memorial Care Innovation Fund also participated in the round. Aventura will use proceeds from the funding to expand sales and marketing, business development, and customer support, as well as accelerate product development.
SFE: 18.54 (+0.06), MRK: 58.81 (-0.07)
Safeguard Scientifics to Release Fourth Quarter and Full-Year 2014 Financial Results on Thursday, March 5th
GlobeNewswire - Thu Feb 05, 10:00AM CST
via PRWEB - Safeguard Scientifics, Inc. (NYSE:SFE) will release its financial results for the fourth quarter and year-ended December 31, 2014 prior to market open on Thursday, March 5, 2015.
SFE: 18.54 (+0.06)
Velano Vascular Raises $5 Million Series A Financing Led by First Round Capital, Two Hospitals and Notable Healthcare Industry Veterans
Business Wire - Thu Feb 05, 6:31AM CST
Velano Vascular, a medical technology company with the goal of reducing needle sticks during the inpatient blood draw procedure, today announced that the company has closed a $5 million Series A financing. Investors include First Round Capital, White Owl Capital, Kapor Capital, and Safeguard Scientifics (NYSE: SFE), in addition to health-industry angels and two thought-leading hospitals. Velano Vascular plans to use proceeds from this financing to move into clinical evaluation and early commercialization with select hospital partners.
SFE: 18.54 (+0.06)
Trice Medical Extends Series B Financing to $18.1 Million
GlobeNewswire - Wed Feb 04, 7:06AM CST
via PRWEB - Trice Medical(TM), a private diagnostics company focused on micro invasive technologies, today announced that it closed its Series B financing totaling $18.1 million. The company raised an additional $6.5 million to supplement the initial $11.6 million, which was announced in July 2014. HealthQuest Capital led the extension. Safeguard Scientifics, Inc. (NYSE:SFE) provided an additional $1.15 million in the extension to bring its total capital deployed to $6.15 million. BioStar Ventures and other existing investors completed the round. Proceeds will be used to support Trice Medical's commercialization and marketing of its initial diagnostic arthroscopy product, mi-eye(TM), into the physician's office.
SFE: 18.54 (+0.06)
U.S. Congressman Patrick Meehan to Present Keynote Address at 22nd Annual Groundhog Investment Forum
Business Wire - Tue Feb 03, 9:15AM CST
Emerald Asset Management, Inc. has announced that U.S. Congressman Patrick Meehan will present the keynote address to the close the 22nd annual Groundhog Day Investment Forum on Thursday, February 5th in Philadelphia. Currently serving his third term in Congress, Congressman Meehan represents Pennsylvania's 7th Congressional District, serving on the influential House Ways and Means Committee, as well as the Committee on Ethics. In the 113th Congress, Meehan chaired the House Homeland Security Committee's Subcommittee on Cybersecurity. Meehan focused on protecting America's critical infrastructure -- our transportation, energy, financial and communications systems -- from cyberattack. "Cybersecurity is a critical issue for our nation and for every American company," said Emerald CEO Joseph E. Besecker. "We welcome Congressman Meehan and his are eager to hear about Washington's ongoing efforts to protect the Homeland, including our vital technology-related assets," he said. Among the investment themes for 2015 identified by Emerald is the growing attention to cybersecurity and companies that provide related services and solutions.
SFE: 18.54 (+0.06), CODI: 16.61 (+0.03), MATW: 49.13 (+0.73), CUBI: 22.29 (-0.14), SASR: 25.85 (-0.18), TREX: 44.63 (-0.01), SN: 15.21 (-0.12), RBPAA: 1.83 (+0.02), STON: 28.02 (-0.32), INO: 6.80 (-0.15), WTR: 25.85 (-0.45), ALNY: 95.54 (+1.67), STBA: 28.60 (+0.03), MRNS: 10.94 (-0.06), APOG: 45.54 (+0.27), KWR: 86.40 (+1.20), BMTC: 29.89 (-0.01), EPAM: 54.08 (-1.93), ACTA: 16.07 (+0.08), GSVC: 10.22 (+0.12)
Investment Industry to Gather in Philadelphia at 22nd Annual Groundhog Day Investment Forum
Business Wire - Thu Jan 29, 11:05AM CST
Emerald Asset Management, Inc. will welcome hundreds of investment industry professionals to the 22nd annual Emerald Groundhog Day Investment Forum, scheduled to be held on Thursday, February 5th at the Radisson Blu Warwick Hotel in Philadelphia, PA. "Each year we say that the investment year begins in earnest with our annual Forum," said Emerald CEO and Founder Joseph E. Besecker. "This year with increased market volatility and an uncertain economic outlook, hearing directly from corporate leaders and our team of analysts and portfolio managers is even more imperative," he said. Public company senior managers, investment portfolio managers and research analysts come together to review 2014 and provide their initial outlook to 2015 and beyond. This year's Forum will include sessions focusing on cyber security, advances in biotechnology, community and regional banks, income-oriented and alternative investments and ongoing innovations by corporate America generating potential investment opportunities.
SFE: 18.54 (+0.06), MATW: 49.13 (+0.73), CUBI: 22.29 (-0.14), SASR: 25.85 (-0.18), TREX: 44.63 (-0.01), SN: 15.21 (-0.12), RBPAA: 1.83 (+0.02), STON: 28.02 (-0.32), INO: 6.80 (-0.15), WTR: 25.85 (-0.45), ALNY: 95.54 (+1.67), STBA: 28.60 (+0.03), MRNS: 10.94 (-0.06), APOG: 45.54 (+0.27), KWR: 86.40 (+1.20), BMTC: 29.89 (-0.01), EPAM: 54.08 (-1.93), ACTA: 16.07 (+0.08), GSVC: 10.22 (+0.12)
Raymond Hill, Former IMS and InVentiv Health Executive, Joins Medivo's Board of Directors
GlobeNewswire - Mon Nov 17, 7:19AM CST
via PRWEB - Medivo, Inc., a leader in lab data analytics, today announced that Raymond Hill has been elected to Medivo's board of directors. As President of InVentiv Health Clinical, Mr. Hill was instrumental in driving EBITDA growth, reducing attrition, securing key strategic partnerships, and re-positioning the company. As President of IMS Consulting and Services, Mr. Hill spearheaded work in portfolio strategy, pricing and market access, launch excellence, managed markets, sales force effectiveness, and commercial outsourcing. Mr. Hill also served as the CEO of Pharmaceutical Product Development Inc.
SFE: 18.54 (+0.06)
Safeguard Scientifics Appoints Mara G. Aspinall to its Board of Directors
PRWeb - Mon Oct 27, 8:07AM CDT
Safeguard Scientifics, Inc. (NYSE:SFE) today announced that it appointed Mara G. Aspinall to its board of directors. Ms. Aspinall has a track record of success as an entrepreneur and healthcare industry visionary that will drive value for Safeguard's shareholders. Inclusive of Aspinall's appointment, Safeguard currently has nine board members.
SFE: 18.54 (+0.06)
Safeguard Scientifics' (SFE) CEO Stephen Zarrilli on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Fri Oct 24, 10:51AM CDT
SFE: 18.54 (+0.06)
Safeguard Scientifics Announces Third Quarter 2014 Financial Results
GlobeNewswire - Fri Oct 24, 5:19AM CDT
via PRWEB - Safeguard Scientifics, Inc. (NYSE:SFE) today announced third quarter 2014 financial results. For the three months ended September 30, 2014, Safeguard's net loss was $14.0 million, or $0.68 per share, compared to a net loss of $19.4 million, or $0.90 per share, for the same period in 2013. For the nine months ended September 30, 2014, Safeguard's net income was $10.0 million, or $0.47 per share, compared to a net loss of $59.5 million, or $2.80 per share, for the same period of 2013.
SFE: 18.54 (+0.06)
Safeguard Scientifics misses by $0.13
Seeking Alpha - at Seeking Alpha - Fri Oct 24, 5:17AM CDT
SFE: 18.54 (+0.06)
Notable earnings before Friday’s open
Seeking Alpha - at Seeking Alpha - Thu Oct 23, 4:30PM CDT
WYN: 90.57 (+0.93), SFE: 18.54 (+0.06), F: 16.30 (-0.06), OCR: 76.89 (+0.14), B: 37.40 (+0.44), SXC: 17.32 (+0.58), VTR: 76.61 (-0.41), UPS: 101.79 (+0.38), DLPH: 78.70 (+0.64), CHH: 61.75 (+1.14), LYB: 89.99 (+0.19), COG: 28.10 (+0.18), SHPG: 239.82 (+6.11), TCB: 15.86 (+0.03), AVY: 53.79 (+0.14), AAN: 31.35 (-0.09), MGLN: 60.98 (+0.10), STT: 76.93 (-0.46), FNFG: 8.84 (+0.04), IMGN: 7.19 (unch), EDU: 18.79 (+0.01), BMY: 60.04 (+0.56), DTE: 81.56 (-2.43), LEA: 108.70 (-0.73), MCO: 98.22 (+0.01), FLIR: 33.01 (-0.23), IMS: 25.68 (+0.22), LPNT: 69.04 (-0.06), ERIC: 12.77 (-0.02), PG: 85.90 (-0.13), IDXX: 159.08 (+1.72), WBC: 109.54 (+6.48), NDAQ: 49.48 (-0.27), CL: 70.08 (+0.23)
Safeguard Scientifics' CEO Hosts 2014 Investor Day Conference (Transcript)
SA Transcripts - at Seeking Alpha - Wed Oct 15, 9:04PM CDT
SFE: 18.54 (+0.06)
